D3 5,000
Single vitamin or mineral · 90 servings · $33.00 · 4.7 stars from 63 reviews
Worth trying for Brain health
May help: dementia risk
- Evidence Worth trying
- Dose 1 of 1 at a studied dose
- Safety Read the label's warnings
- Fillers None of concern
What's in it
The dose here lands inside the range studies actually used.
Supplement Facts
Serving Size: 1 Softgel(s)
90 per container
- Vitamin D3 as Cholecalciferol 125 mcg 625%
Other ingredients: Extra Virgin Olive Oil, Bovine Gelatin, Glycerin, Water, Purified.
Directions: Take 1 softgel daily, or use as directed by your healthcare professional.
Doses against the trials
-

Vitamin D3
At the studied dose
125 mcg a day studies used 5–300 mcg · 115 studies
What it's sold for
-
Brain health
Worth trying
-
Musculoskeletal health
Worth trying
-
Mood support
Unproven
-
Healthy blood sugar
Not backed
-
Bone health
Not backed
Stronger bones, fewer fractures: doesn't help
-
Immune support
Not backed
-
Cardiovascular health
Not backed
-
Calcium absorption
Not backed
Stronger bones, fewer fractures: doesn't help
-
Muscle health
Not backed
Worth knowing
The label's warnings
Consult your healthcare professional prior to use.
Individuals taking medication should discuss potential interactions with their healthcare professional.
Storage: Keep closed in a cool, dry place out of reach of children.
Reported side effects
Hypercalciuria, Nausea, Hypercalcemia, Headache, Dizziness, Hypercalcaemia
The other ingredients
Clean formula. The inactive ingredients are standard capsule components.
- Extra Virgin Olive Oil
- Bovine Gelatin: capsule shell; neutral unless ethical concern
- Glycerin: capsule plasticizer; benign
- Water, Purified
Free from
Gluten Free, Dairy Free. Formulated to Exclude: Wheat, gluten, yeast, soy, dairy products, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, and artificial sweeteners.
XYMOGEN
80 out of 100
Brand audit score
XYMOGEN shows a solid quality posture with NSF Certified for Sport listings and public company disclosures, but the available evidence remains limited.





